about
Interaction between therapeutic interventions for Alzheimer's disease and physiological Aβ clearance mechanismsGenerating Gene Ontology-Disease Inferences to Explore Mechanisms of Human Disease at the Comparative Toxicogenomics DatabaseResting-state functional MR imaging shed insights into the brain of diabetes.Ghrelin is a possible new predictor associated with executive function in patients with type 2 diabetes mellitus.The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.Effect of diabetes on caregiver burden in an observational study of individuals with Alzheimer's disease.Dissociation between Conceptual and Perceptual Implicit Memory: Evidence from Patients with Frontal and Occipital Lobe Lesions.Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's diseaseSimilar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years.Agrimonia pilosa Ledeb., Cinnamomum cassia Blume, and Lonicera japonica Thunb. protect against cognitive dysfunction and energy and glucose dysregulation by reducing neuroinflammation and hippocampal insulin resistance in β-amyloid-infused rats.Evaluating the Role of Hormone Therapy in Postmenopausal Women with Alzheimer's Disease.Dynamics of diabetes and obesity: Epidemiological perspective.Glycation induces conformational changes in the amyloid-β peptide and enhances its aggregation propensity: molecular insights.Outcomes and healthcare resource utilization associated with medically attended hypoglycemia in older patients with type 2 diabetes initiating basal insulin in a US managed care setting.Subcortical Atrophy in Cognitive Impairment and Dementia.Metabolic parameters and cognitive function in a cohort of older diabetic patients.Ameliorating effect of anti-Alzheimer's drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer's disease.Blood-Brain Barrier Dysfunction Precedes Cognitive Decline and Neurodegeneration in Diabetic Insulin Resistant Mouse Model: An Implication for Causal Link.Amylin in Alzheimer's disease: Pathological peptide or potential treatment?Effects of GABAB receptor activation on spatial cognitive function and hippocampal neurons in rat models of type 2 diabetes mellitus.Effect of Passage Number and Culture Time on the Expression and Activity of Insulin-Degrading Enzyme in Caco-2 CellsHidden heterogeneity in Alzheimer's disease: Insights from genetic association studies and other analyses.Anti-apoptotic and antioxidant effects of low dose gamma irradiation against diabetes-induced brain injury in rats.Hyperglycemia Increases the Production of Amyloid Beta-Peptide Leading to Decreased Endothelial Tight Junction.Word-stem priming and recognition in type 2 diabetes mellitus, Alzheimer's disease patients and healthy older adults.Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer's Disease.Metformin Attenuates Aβ Pathology Mediated Through Levamisole Sensitive Nicotinic Acetylcholine Receptors in a C. elegans Model of Alzheimer's Disease.Influence of diabetes on plasma pharmacokinetics and brain bioavailability of grape polyphenols and their phase II metabolites in the Zucker diabetic fatty rat.12th Key Symposium Introduction: insulin resistance in common diseases.PKR modulates abnormal brain signaling in experimental obesity.Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits.Elucidating the multi-targeted anti-amyloid activity and enhanced islet amyloid polypeptide binding of -wrapinsCharacterisation of the Structure and Oligomerisation of Islet Amyloid Polypeptides (IAPP): A Review of Molecular Dynamics Simulation StudiesCognitive deficits and Alzheimer-like neuropathological impairments during adolescence in a rat model of type 2 diabetes mellitus
P2860
Q27001177-F6C7E752-CC5A-4354-ADA1-4BD8B0BF243EQ28551995-96BD5C9C-1B22-4F61-94AF-E6BA6CA39E3AQ31117440-2C5C3C76-C299-4523-89EF-34F8AE167780Q33633591-939F8DBD-DAC2-4FB1-992D-A6895DECAF21Q35800000-7BB2ED11-D939-440E-A6C5-18A56A388F71Q36007975-8691F419-65BA-4B50-8CA0-6804C514BD40Q36458342-50C01115-FEA9-437F-955B-708B7C9D1BD0Q36767796-091EEBB3-A04E-40C3-8AA1-E9AADBE197BBQ37384963-2DABCD52-8A43-4C6B-AFC6-48C8288B078CQ38417573-C11DE21A-2223-4AC4-A68D-A0D7A218A855Q38814359-7EBF522C-B3A9-4EE8-A0B6-0158E3F0BBFCQ38994655-C52C80C4-3F73-4D47-9F62-09BFEC277080Q39202379-8611ADE1-D3A8-4353-A7C3-5F1181CA9CBDQ39770614-763F83BE-19CD-4EB1-B4B8-19A3065F94C5Q40506863-DF69A6BF-E1BE-44CD-ABA1-079B1E6A0236Q41002434-1B1939AF-6D5A-4B58-A9C8-F5E810345E7FQ46455298-8352098F-853B-4751-905B-8C5EA0641A31Q47106839-437E1314-2388-45D9-9A09-2E0C410163D7Q47322028-17019D0E-EF8A-4A04-8B7D-0D8D359D3115Q47364294-8C93B679-03D0-42C3-91F4-3C3A613851CEQ47390693-A0DA953D-7D04-4F34-831F-5621CBFA0003Q47625969-9685FAEE-8A21-4560-A05C-608494F826BBQ48446683-F5116F82-661C-4AF0-899E-46E61004FFFDQ48930602-390C69C6-1968-4A9D-A661-0394A0A2A532Q50572130-08CD835D-712D-451D-818D-4AAAAB765357Q50582002-C7839310-5F25-4F45-97EC-4E4CE02AA7B8Q51533022-9059FBFF-CF3B-45A9-8588-907F60F52141Q52092978-7C4E084E-00EB-4F70-B22B-E6D5CFC00CCCQ53765595-E66A057F-5F48-4894-838B-6D393E17E70FQ54978322-65B35831-EF91-4686-96FC-43692C9E8B90Q55353865-2C249A15-0AFC-46D7-991B-0C2FB185DD24Q58566190-52158AEC-C417-4C01-8CD7-2E4C2508248CQ58696552-1CB48C72-B431-4936-9B26-7FA8E24CD391Q58702626-40B78332-A74E-45DE-9887-265DD2BE9A20
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Type 2 diabetes mellitus and Alzheimer's disease.
@ast
Type 2 diabetes mellitus and Alzheimer's disease.
@en
Type 2 diabetes mellitus and Alzheimer's disease.
@nl
type
label
Type 2 diabetes mellitus and Alzheimer's disease.
@ast
Type 2 diabetes mellitus and Alzheimer's disease.
@en
Type 2 diabetes mellitus and Alzheimer's disease.
@nl
prefLabel
Type 2 diabetes mellitus and Alzheimer's disease.
@ast
Type 2 diabetes mellitus and Alzheimer's disease.
@en
Type 2 diabetes mellitus and Alzheimer's disease.
@nl
P2860
P356
P1476
Type 2 diabetes mellitus and Alzheimer's disease.
@en
P2093
Ligia J Dominguez
Mario Barbagallo
P2860
P304
P356
10.4239/WJD.V5.I6.889
P577
2014-12-01T00:00:00Z